Skip to search formSkip to main contentSkip to account menu

AK 2123

Known as: 1H-1,2,4-Triazole-1-acetamide, N-(2-methoxyethyl)-3-nitro-, AK-2123 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
PURPOSE AK-2123, a nitrotriazole hypoxic cell sensitizer has reportedly improved results in head and neck cancers, uterine… 
2005
2005
Sanazole (AK-2123, 3-nitrotriazole derivative, N1-(3-methoxypropyl)-2-(3-nitro-1 H-1,2,4-triazol-1-yl)acetamide) and nimorazole… 
2005
2005
An attempt was made to evaluate the whole body γ-radiation effect on tumor in the presence of free and liposome encapsulated AK… 
2003
2003
Sanazole/AK-2123/γ-Radiation/DNA damage/Apoptosis/Radiosensitizer. Sanazole (AK-2123) (N-2′-methoxy ethyl)-2-(3″-nitro-1… 
2003
2003
Sanazole (AK-2123) (N-2'-methoxy ethyl)-2-(3"-nitro-1"-triazolyl)acetamide, which has completed phase III clinical trials as a… 
2001
2001
Sanazole/DNA repair/Hypoxic radiosensitization/DNA polymerases/Saccharomyces cerevisiae Yeast Saccharomyces cerevisiae can exist… 
2000
2000
The redox chemistry of sanazole, an efficient hypoxic cell radiosensitizer, generally referred to as AK-2123, was studied by… 
1996
1996
The in vivo response of a transplantable mouse tumour, Sarcoma 180 to AK-2123 (AK), local irradiation (RT) and local hyperthermia… 
1995
1995
We investigated to clarify the mechanism of action of AK-2123. V79 cells were used, and the effect of the substance was estimated…